Apotea AB

Good morning everyone and welcome to Apotea's presentation of our fourth quarter report. This is also our first report as a listed company which we are very excited about of course. We will present today from our head office here in Stockholm and we will start with the presentation and then after the presentation is finished we will move on to a Q&A with spoken questions. Today's presenters will be Per Svadsson, our CEO and co-founder, together with Johan Mohild, our CFO, and together with myself, Sara Ahnström, COO.

So, hello. I think we had a very good quarter and with strong growth and increased profitability and we started also a lot of exciting projects so I think we're well prepared for the future but Johan let's guide us into the figures yes we had revenues of 1.7 billion in the quarter and growth of 15.8% the adjusted EBIT margin was 3.9% and we had a sustained high inventory turnover of close to 10x And if we look a little bit on this quarter, I mean, I think you know that we had a successful IPO in December and we welcomed more than 90,000 new owners and we're very proud of that. We also worked quite hard to increase our Rx capacity. that's important because to sell prescription medicine we need to have capacity because we have a lot of demand out there but we need to have this capacity and we focused on building this capacity and I think when we move forward and look into the figures we can see that the growth of the prescription is very high and that's because of this. And we took actually a new record with almost 20,000 orders in just one day. Another thing is that our Varberg project, we start to install the automation in Varberg in October. And you can really see, we visited Varberg just a few weeks ago, and it's fantastic to see. So it's on track.

Yes, a key event of the quarter was also our Black Week campaign, and we were very happy to see that it was successfully executed, much due to our increased capacity, hence also our increased automation. And during these intense days, we also delivered up to close to, I would say, 90,000 orders in a day. We have also focused quite a lot still in expanding our assortment and we currently have the largest assortment of pharmacy products in the market, close to 53,000 products. We also launched several new products over our own products during the quarter and ended the year with 270 own private label products for sale on our site.